MELATONIN

MELATONIN was reported 55488 times

These side effects are most commonly reported by patients taking MELATONIN:

# Side effect Count
0 FATIGUE 4565
1 NAUSEA 3858
2 OFF LABEL USE 3541
3 DRUG INEFFECTIVE 3313
4 DIARRHOEA 3101
5 HEADACHE 3061
6 DYSPNOEA 2653
7 INSOMNIA 2564
8 FALL 2496
9 PAIN 2422
10 DIZZINESS 2399
11 VOMITING 2298
12 DEATH 2238
13 ASTHENIA 1996
14 SOMNOLENCE 1982
15 CONSTIPATION 1967
16 ANXIETY 1811
17 PNEUMONIA 1760
18 ARTHRALGIA 1631
19 CONDITION AGGRAVATED 1617
20 PRODUCT DOSE OMISSION ISSUE 1586
21 WEIGHT DECREASED 1576
22 MALAISE 1535
23 COUGH 1489
24 DEPRESSION 1382
25 DECREASED APPETITE 1355
26 PYREXIA 1355
27 RASH 1332
28 PRURITUS 1326
29 PAIN IN EXTREMITY 1315
30 URINARY TRACT INFECTION 1274
31 CONFUSIONAL STATE 1263
32 ABDOMINAL PAIN 1254
33 WEIGHT INCREASED 1237
34 FEELING ABNORMAL 1213
35 TREMOR 1210
36 BACK PAIN 1173
37 SEIZURE 1132
38 GAIT DISTURBANCE 1126
39 HYPERTENSION 1090
40 HYPOTENSION 1038
41 PRODUCT USE IN UNAPPROVED INDICATION 1018
42 HALLUCINATION 996
43 COVID-19 979
44 MUSCLE SPASMS 973
45 NASOPHARYNGITIS 963
46 ACUTE KIDNEY INJURY 904
47 DRUG INTERACTION 898
48 ABDOMINAL PAIN UPPER 885
49 GASTROOESOPHAGEAL REFLUX DISEASE 881
50 ANAEMIA 876
51 MEMORY IMPAIRMENT 815
52 PERIPHERAL SWELLING 811
53 SEPSIS 811
54 ABDOMINAL DISTENSION 798
55 CHEST PAIN 788
56 BLOOD PRESSURE INCREASED 785
57 INTENTIONAL OVERDOSE 782
58 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 758
59 SLEEP DISORDER 755
60 SUICIDAL IDEATION 730
61 ABDOMINAL DISCOMFORT 729
62 BALANCE DISORDER 724
63 GENERAL PHYSICAL HEALTH DETERIORATION 717
64 PRODUCT USE ISSUE 715
65 DEHYDRATION 707
66 MYALGIA 704
67 MUSCULAR WEAKNESS 695
68 PARAESTHESIA 685
69 AGITATION 681
70 SINUSITIS 681
71 STRESS 680
72 HOSPITALISATION 663
73 HYPOAESTHESIA 655
74 ALOPECIA 637
75 DRY MOUTH 635
76 CONTUSION 629
77 INFLUENZA 618
78 VISION BLURRED 607
79 DRUG HYPERSENSITIVITY 594
80 HYPERHIDROSIS 584
81 LOSS OF CONSCIOUSNESS 582
82 HEART RATE INCREASED 581
83 OEDEMA PERIPHERAL 580
84 INJECTION SITE PAIN 578
85 HYPONATRAEMIA 575
86 INTENTIONAL SELF-INJURY 567
87 ERYTHEMA 565
88 INFECTION 564
89 DYSPHAGIA 554
90 ILLNESS 546
91 HYPERSENSITIVITY 539
92 NEUROPATHY PERIPHERAL 539
93 MIGRAINE 531
94 TACHYCARDIA 518
95 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 517
96 INTENTIONAL PRODUCT MISUSE 510
97 SWELLING 510
98 ASTHMA 508
99 MUSCULOSKELETAL STIFFNESS 505
100 PALPITATIONS 502
101 AGGRESSION 500
102 CHRONIC KIDNEY DISEASE 500
103 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 498
104 OROPHARYNGEAL PAIN 498
105 DYSKINESIA 490
106 RENAL FAILURE 488
107 WHITE BLOOD CELL COUNT DECREASED 488
108 INCORRECT DOSE ADMINISTERED 486
109 OVERDOSE 478
110 URTICARIA 476
111 CHILLS 474
112 TOXICITY TO VARIOUS AGENTS 472
113 DRUG INTOLERANCE 469
114 PNEUMONIA ASPIRATION 468
115 PLATELET COUNT DECREASED 467
116 ATRIAL FIBRILLATION 464
117 HAEMOGLOBIN DECREASED 461
118 DYSPEPSIA 459
119 THROMBOSIS 443
120 HOT FLUSH 436
121 COMA 433
122 VISUAL IMPAIRMENT 433
123 PULMONARY EMBOLISM 428
124 FLUSHING 419
125 INTENTIONAL PRODUCT USE ISSUE 418
126 EPISTAXIS 417
127 ASCITES 416
128 BRONCHITIS 416
129 MULTIPLE ORGAN DYSFUNCTION SYNDROME 416
130 PRODUCTIVE COUGH 413
131 IRRITABILITY 412
132 FEBRILE NEUTROPENIA 411
133 DISTURBANCE IN ATTENTION 410
134 OXYGEN SATURATION DECREASED 410
135 GASTROINTESTINAL DISORDER 404
136 CEREBROVASCULAR ACCIDENT 401
137 COGNITIVE DISORDER 401
138 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 399
139 SYNCOPE 398
140 CHEST DISCOMFORT 396
141 PARKINSON^S DISEASE 395
142 LETHARGY 385
143 MOBILITY DECREASED 382
144 SUICIDE ATTEMPT 381
145 DISEASE PROGRESSION 379
146 DRY SKIN 378
147 JOINT SWELLING 376
148 UPPER RESPIRATORY TRACT INFECTION 373
149 SPEECH DISORDER 371
150 ABNORMAL BEHAVIOUR 370
151 BLOOD CHOLESTEROL INCREASED 368
152 NEURALGIA 363
153 CARDIAC ARREST 362
154 RHINORRHOEA 362
155 NEUTROPENIA 356
156 NASAL CONGESTION 355
157 RESPIRATORY FAILURE 353
158 NECK PAIN 350
159 BLOOD GLUCOSE INCREASED 348
160 DRUG DOSE OMISSION 346
161 EYE PAIN 346
162 AMNESIA 345
163 PLEURAL EFFUSION 345
164 RESTLESSNESS 342
165 DYSPNOEA EXERTIONAL 338
166 COMPLETED SUICIDE 336
167 DIABETES MELLITUS 335
168 DEPRESSED MOOD 334
169 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 331
170 DEVICE ISSUE 330
171 PRODUCT QUALITY ISSUE 328
172 UNEVALUABLE EVENT 322
173 HALLUCINATION, VISUAL 321
174 THROMBOCYTOPENIA 319
175 FLATULENCE 316
176 WHEEZING 315
177 BLOOD CREATININE INCREASED 312
178 APPENDICITIS 309
179 FEELING HOT 305
180 CELLULITIS 304
181 CARDIOGENIC SHOCK 303
182 DYSARTHRIA 303
183 NO ADVERSE EVENT 303
184 ARTHRITIS 301
185 FLUID RETENTION 299
186 HYPOXIA 299
187 HEPATIC ENZYME INCREASED 298
188 STOMATITIS 296
189 BLOOD PRESSURE DECREASED 294
190 DYSPHONIA 293
191 HYPERSOMNIA 293
192 TRANSIENT ISCHAEMIC ATTACK 292
193 INFUSION RELATED REACTION 286
194 NEPHROLITHIASIS 286
195 ALANINE AMINOTRANSFERASE INCREASED 283
196 MALIGNANT NEOPLASM PROGRESSION 283
197 CARDIAC FAILURE CONGESTIVE 281
198 INFLUENZA LIKE ILLNESS 281
199 THERAPY INTERRUPTED 281
200 OEDEMA 280
201 ASPARTATE AMINOTRANSFERASE INCREASED 278
202 UNDERDOSE 278
203 DELIRIUM 276
204 APPENDICOLITH 275
205 JOINT INJURY 273
206 PRODUCT DOSE OMISSION 272
207 ADVERSE DRUG REACTION 270
208 DRY EYE 267
209 MENTAL STATUS CHANGES 267
210 PRODUCT SUBSTITUTION ISSUE 267
211 CARDIAC DISORDER 265
212 VENTRICULAR FIBRILLATION 265
213 TINNITUS 263
214 BONE PAIN 262
215 PANIC ATTACK 262
216 POOR QUALITY SLEEP 261
217 SLEEP APNOEA SYNDROME 260
218 DRUG DEPENDENCE 257
219 VERTIGO 257
220 SKIN EXFOLIATION 255
221 CRYING 254
222 DRUG ABUSE 254
223 CATARACT 252
224 DYSGEUSIA 251
225 THERAPY CESSATION 248
226 ANGER 246
227 HERPES ZOSTER 246
228 THERAPEUTIC RESPONSE UNEXPECTED 246
229 NIGHTMARE 245
230 POLLAKIURIA 244
231 BACTERIAL INFECTION 243
232 RENAL IMPAIRMENT 243
233 EAR INFECTION 241
234 EMOTIONAL DISTRESS 241
235 HYPOKALAEMIA 241
236 GASTROINTESTINAL HAEMORRHAGE 240
237 SURGERY 240
238 HAEMORRHAGE 238
239 INFUSION SITE PAIN 238
240 DISORIENTATION 237
241 CARDIAC FAILURE 236
242 MENTAL DISORDER 235
243 MYOCARDIAL INFARCTION 235
244 END STAGE RENAL DISEASE 233
245 HEAD INJURY 231
246 RESTLESS LEGS SYNDROME 230
247 RASH PRURITIC 229
248 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 228
249 BURNING SENSATION 227
250 DEPRESSED LEVEL OF CONSCIOUSNESS 227
251 PSORIASIS 226
252 URINARY INCONTINENCE 225
253 NERVOUSNESS 224
254 ACUTE RESPIRATORY FAILURE 222
255 GAIT INABILITY 222
256 MYASTHENIA GRAVIS 221
257 DELUSION 220
258 LUNG DISORDER 220
259 VIRAL INFECTION 220
260 MICTURITION URGENCY 218
261 THROAT IRRITATION 218
262 WHITE BLOOD CELL COUNT INCREASED 217
263 DEMENTIA 216
264 UNRESPONSIVE TO STIMULI 216
265 BRADYCARDIA 215
266 HYPOPHAGIA 215
267 INJECTION SITE ERYTHEMA 215
268 LOWER RESPIRATORY TRACT INFECTION 214
269 CORONARY ARTERY DISEASE 213
270 FULL BLOOD COUNT ABNORMAL 212
271 MULTIPLE SCLEROSIS RELAPSE 212
272 PSYCHOTIC DISORDER 210
273 URINARY RETENTION 208
274 HIP FRACTURE 207
275 ABNORMAL DREAMS 206
276 DEEP VEIN THROMBOSIS 204
277 SWELLING FACE 204
278 HEART RATE DECREASED 203
279 RHEUMATOID ARTHRITIS 203
280 SEDATION 203
281 DYSSTASIA 201
282 RED BLOOD CELL COUNT DECREASED 201
283 DEVICE DISLOCATION 200
284 ELECTROCARDIOGRAM QT PROLONGED 200
285 HAEMATOCHEZIA 198
286 MIDDLE INSOMNIA 197
287 PRODUCT PRESCRIBING ERROR 197
288 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 195
289 WITHDRAWAL SYNDROME 195
290 BLISTER 194
291 DYSURIA 194
292 INJECTION SITE BRUISING 194
293 SEASONAL ALLERGY 194
294 BLOOD PHOSPHORUS INCREASED 193
295 TREATMENT NONCOMPLIANCE 193
296 PAIN IN JAW 192
297 INTENTIONAL DOSE OMISSION 191
298 PANCYTOPENIA 190
299 BENIGN PROSTATIC HYPERPLASIA 189
300 PSYCHOMOTOR HYPERACTIVITY 189
301 ACNE 188
302 APHASIA 188
303 BLOOD POTASSIUM DECREASED 188
304 NIGHT SWEATS 188
305 GENERALISED TONIC-CLONIC SEIZURE 187
306 OSTEOARTHRITIS 186
307 SKIN DISCOLOURATION 186
308 COLITIS 185
309 BREATH SOUNDS ABNORMAL 183
310 MUSCLE TWITCHING 183
311 BRONCHIECTASIS 182
312 LIMB DISCOMFORT 182
313 THERAPY NON-RESPONDER 181
314 BLOOD PRESSURE FLUCTUATION 179
315 MOVEMENT DISORDER 179
316 MUSCULOSKELETAL PAIN 179
317 HOSPICE CARE 178
318 HYPOPHOSPHATAEMIA 177
319 MENTAL IMPAIRMENT 177
320 ADVERSE EVENT 176
321 ARTHROPATHY 176
322 BLOOD URIC ACID INCREASED 175
323 ILL-DEFINED DISORDER 175
324 LIMB INJURY 174
325 OSTEOPOROSIS 174
326 DISCOMFORT 173
327 EYE IRRITATION 173
328 ROAD TRAFFIC ACCIDENT 172
329 SEROTONIN SYNDROME 172
330 OCULAR HYPERAEMIA 171
331 INTESTINAL OBSTRUCTION 169
332 CONGENITAL HIATUS HERNIA 168
333 GOUT 168
334 THERAPEUTIC PRODUCT EFFECT DECREASED 168
335 GASTROENTERITIS VIRAL 166
336 INFUSION SITE ERYTHEMA 166
337 RESPIRATORY DEPRESSION 165
338 CROHN^S DISEASE 164
339 DRUG WITHDRAWAL SYNDROME 164
340 CYSTITIS 163
341 FUNGAL INFECTION 163
342 ENCEPHALOPATHY 160
343 HYPERPHOSPHATAEMIA 160
344 MULTIPLE SCLEROSIS 160
345 SEPTIC SHOCK 160
346 CLOSTRIDIUM DIFFICILE INFECTION 159
347 BRAIN FOG 158
348 DERMATITIS ATOPIC 158
349 HYPERLIPIDAEMIA 158
350 LIVER FUNCTION TEST INCREASED 158
351 RESPIRATORY DISTRESS 157
352 STAPHYLOCOCCAL INFECTION 157
353 APLASTIC ANAEMIA 156
354 HYPERCHOLESTEROLAEMIA 156
355 LYMPHADENOPATHY 156
356 METABOLIC ACIDOSIS 155
357 RESPIRATORY TRACT INFECTION 155
358 THERAPEUTIC RESPONSE SHORTENED 155
359 INITIAL INSOMNIA 154
360 ORTHOSTATIC HYPOTENSION 153
361 DYSTONIA 152
362 FEELING COLD 152
363 HAEMOPTYSIS 152
364 HYPOACUSIS 152
365 INJURY 152
366 ECZEMA 151
367 ON AND OFF PHENOMENON 151
368 PULMONARY OEDEMA 151
369 SKIN BURNING SENSATION 151
370 EMOTIONAL DISORDER 150
371 INFLAMMATION 150
372 MOOD ALTERED 150
373 MOOD SWINGS 150
374 EATING DISORDER 149
375 INJECTION SITE PRURITUS 149
376 RHABDOMYOLYSIS 149
377 HYPOTHYROIDISM 148
378 PRODUCT DOSE OMISSION IN ERROR 148
379 RASH ERYTHEMATOUS 148
380 INFUSION SITE SWELLING 147
381 PARANOIA 146
382 INJECTION SITE REACTION 144
383 INJECTION SITE SWELLING 143
384 RETCHING 143
385 RIB FRACTURE 143
386 DIPLOPIA 142
387 NEUTROPHIL COUNT DECREASED 141
388 THINKING ABNORMAL 141
389 ASPIRATION 140
390 LIVER DISORDER 139
391 RECTAL HAEMORRHAGE 139
392 RENAL DISORDER 138
393 OBESITY 137
394 PANCREATITIS 137
395 BLOOD PRESSURE ABNORMAL 135
396 INJECTION SITE HAEMORRHAGE 135
397 OBSTRUCTIVE AIRWAYS DISORDER 135
398 PRE-EXISTING CONDITION IMPROVED 135
399 SINUS DISORDER 135
400 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 134
401 JOINT STIFFNESS 134
402 INCREASED APPETITE 133
403 SKIN LACERATION 133
404 DIVERTICULITIS 132
405 CHOLELITHIASIS 131
406 MUSCLE TIGHTNESS 131
407 ULCER 131
408 PLASMA CELL MYELOMA 130
409 TROPONIN INCREASED 130
410 ANAL INCONTINENCE 129
411 RASH MACULAR 129
412 THERAPEUTIC RESPONSE DECREASED 129
413 EXTRAPYRAMIDAL DISORDER 128
414 FIBROMYALGIA 128
415 HEART RATE IRREGULAR 128
416 HYPERKALAEMIA 128
417 INCONTINENCE 128
418 EPILEPSY 127
419 FEAR 127
420 HALLUCINATION, AUDITORY 127
421 IRON DEFICIENCY 127
422 LOCALISED INFECTION 127
423 AKATHISIA 126
424 BLOOD PRESSURE SYSTOLIC INCREASED 126
425 DISEASE RECURRENCE 126
426 INTERVERTEBRAL DISC PROTRUSION 126
427 DEVICE OCCLUSION 125
428 ANAPHYLACTIC REACTION 124
429 CONTRAINDICATED PRODUCT ADMINISTERED 124
430 SKIN DISORDER 124
431 RESPIRATORY DISORDER 123
432 INSURANCE ISSUE 122
433 MUSCLE RIGIDITY 122
434 BLOOD TEST ABNORMAL 121
435 FEELING JITTERY 121
436 BLOOD SODIUM DECREASED 120
437 LACRIMATION INCREASED 120
438 TREATMENT FAILURE 120
439 DEVICE LEAKAGE 119
440 ORAL PAIN 119
441 TASTE DISORDER 119
442 FEEDING DISORDER 118
443 PALLOR 118
444 PRESYNCOPE 118
445 ARRHYTHMIA 117
446 C-REACTIVE PROTEIN INCREASED 117
447 HEAD DISCOMFORT 117
448 LYMPHOCYTE COUNT DECREASED 117
449 ANALGESIC THERAPY 116
450 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 115
451 HYPOKINESIA 115
452 MUCOSAL INFLAMMATION 115
453 PRODUCT ADMINISTRATION INTERRUPTED 115
454 CYTOKINE RELEASE SYNDROME 114
455 EYE PRURITUS 114
456 NERVOUS SYSTEM DISORDER 114
457 BLOOD GLUCOSE DECREASED 112
458 IMPAIRED GASTRIC EMPTYING 112
459 SLEEP DISORDER THERAPY 112
460 PRODUCT AVAILABILITY ISSUE 111
461 TARDIVE DYSKINESIA 111
462 DERMATITIS CONTACT 110
463 DROOLING 110
464 DRUG EFFECT DECREASED 110
465 DRUG THERAPY 110
466 GASTRITIS 110
467 PERICARDIAL EFFUSION 110
468 CHOKING 109
469 DEVICE MALFUNCTION 109
470 EAR PAIN 109
471 RESPIRATORY TRACT CONGESTION 109
472 PULMONARY MASS 108
473 SALIVARY HYPERSECRETION 108
474 BEHAVIOUR DISORDER 107
475 CONVULSION 107
476 HAEMATOCRIT DECREASED 107
477 LEUKOPENIA 107
478 LABORATORY TEST ABNORMAL 106
479 MANIA 106
480 NEOPLASM MALIGNANT 106
481 NOCTURIA 106
482 PRESCRIBED OVERDOSE 106
483 PROCEDURAL PAIN 106
484 DEVICE BREAKAGE 105
485 EYE SWELLING 105
486 HEPATIC CYTOLYSIS 105
487 NEOPLASM PROGRESSION 105
488 SINUS TACHYCARDIA 105
489 SNEEZING 105
490 UPPER LIMB FRACTURE 105
491 ACCIDENTAL OVERDOSE 104
492 FAECES DISCOLOURED 104
493 FREEZING PHENOMENON 104
494 LIP SWELLING 104
495 MUSCULOSKELETAL DISORDER 104
496 RENAL INJURY 104
497 TOOTH DISORDER 104
498 WOUND 104
499 BLOOD URINE PRESENT 103
500 HYPOGLYCAEMIA 103
501 BLOOD ALKALINE PHOSPHATASE INCREASED 102
502 COLD SWEAT 102
503 FULL BLOOD COUNT DECREASED 102
504 IMPAIRED HEALING 102
505 TRANSAMINASES INCREASED 102
506 ANHEDONIA 101
507 GASTRIC DISORDER 101
508 HAEMATURIA 101
509 MYDRIASIS 101
510 NEEDLE ISSUE 101
511 ACCIDENTAL EXPOSURE TO PRODUCT 100
512 CARPAL TUNNEL SYNDROME 100
513 FOOT FRACTURE 100
514 PHOTOPHOBIA 100
515 PRESCRIBED UNDERDOSE 100
516 PRODUCT USE COMPLAINT 100
517 SKIN LESION 100
518 BACK DISORDER 99
519 CYANOSIS 99
520 ORAL HERPES 99
521 SOMNAMBULISM 99
522 DECUBITUS ULCER 98
523 PERIPHERAL COLDNESS 98
524 BLOOD CALCIUM INCREASED 97
525 CARDIO-RESPIRATORY ARREST 97
526 COVID-19 PNEUMONIA 97
527 FEMUR FRACTURE 97
528 FREQUENT BOWEL MOVEMENTS 97
529 HYPERGLYCAEMIA 97
530 PNEUMONITIS 97
531 COMPLICATION ASSOCIATED WITH DEVICE 96
532 IMPAIRED WORK ABILITY 96
533 IRRITABLE BOWEL SYNDROME 96
534 PRODUCT STORAGE ERROR 96
535 BODY TEMPERATURE INCREASED 95
536 CANDIDA INFECTION 95
537 CEREBRAL HAEMORRHAGE 95
538 ERUCTATION 95
539 HIATUS HERNIA 95
540 THIRST 95
541 CHROMATURIA 94
542 AORTIC STENOSIS 93
543 BLOOD TRIGLYCERIDES INCREASED 93
544 COLITIS ULCERATIVE 93
545 EYE DISORDER 93
546 SCIATICA 93
547 TENDERNESS 93
548 THROAT TIGHTNESS 93
549 TOOTHACHE 93
550 MUSCULOSKELETAL DISCOMFORT 92
551 MYOCARDITIS 92
552 ALTERED STATE OF CONSCIOUSNESS 91
553 BLOOD BILIRUBIN INCREASED 91
554 MUSCULOSKELETAL CHEST PAIN 91
555 OSTEOPENIA 91
556 SPINAL FRACTURE 91
557 CLOSTRIDIUM DIFFICILE COLITIS 90
558 DRUG EFFECT INCOMPLETE 90
559 INJECTION SITE MASS 90
560 SMALL INTESTINAL OBSTRUCTION 90
561 CLOSTRIDIUM TEST POSITIVE 89
562 HUNGER 89
563 HYPERVOLAEMIA 89
564 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 89
565 POOR VENOUS ACCESS 89
566 PULMONARY HYPERTENSION 89
567 SWOLLEN TONGUE 89
568 BLOOD COUNT ABNORMAL 88
569 EXTRA DOSE ADMINISTERED 88
570 LEUKOCYTOSIS 88
571 NEUTROPHIL COUNT INCREASED 88
572 RASH MACULO-PAPULAR 88
573 SPINAL OSTEOARTHRITIS 88
574 TYPE 2 DIABETES MELLITUS 88
575 DIZZINESS POSTURAL 87
576 HERNIA 86
577 HYPOAESTHESIA ORAL 86
578 MALIGNANT MELANOMA IN SITU 86
579 ORAL CANDIDIASIS 86
580 PSORIATIC ARTHROPATHY 86
581 RASH PAPULAR 86
582 SKIN ULCER 86
583 BEDRIDDEN 85
584 HEPATIC STEATOSIS 85
585 INFUSION SITE HAEMORRHAGE 85
586 IRON DEFICIENCY ANAEMIA 85
587 KIDNEY INFECTION 85
588 MEDICATION ERROR 85
589 PARKINSONISM 85
590 PULMONARY ARTERIAL HYPERTENSION 85
591 SKIN FISSURES 85
592 WEIGHT FLUCTUATION 85
593 BRADYKINESIA 84
594 DRUG-INDUCED LIVER INJURY 84
595 LOWER LIMB FRACTURE 84
596 NEPHROGENIC ANAEMIA 84
597 TIC 84
598 HAEMORRHOIDS 83
599 METASTASES TO LIVER 83
600 SINUS CONGESTION 83
601 ABDOMINAL PAIN LOWER 82
602 NEUROTOXICITY 82
603 SKIN IRRITATION 82
604 MALNUTRITION 81
605 SPUTUM DISCOLOURED 81
606 ANGINA PECTORIS 80
607 BLINDNESS 80
608 CONCUSSION 80
609 DEVICE RELATED INFECTION 80
610 EXPIRED PRODUCT ADMINISTERED 80
611 INFUSION SITE PRURITUS 80
612 MATERNAL EXPOSURE DURING PREGNANCY 80
613 POST PROCEDURAL COMPLICATION 80
614 RESPIRATORY SYNCYTIAL VIRUS INFECTION 80
615 SINUS BRADYCARDIA 80
616 CHOLESTASIS 79
617 IMMUNODEFICIENCY 79
618 LACTIC ACIDOSIS 79
619 ONYCHOCLASIS 79
620 TOOTH INFECTION 79
621 TRANSFUSION 79
622 EXPOSURE DURING PREGNANCY 78
623 PRODUCT ADMINISTRATION ERROR 78
624 SCREAMING 78
625 BLOOD IRON DECREASED 77
626 CARDIOVASCULAR DISORDER 77
627 HAEMATOMA 77
628 MULTIPLE ALLERGIES 77
629 PRODUCT DISTRIBUTION ISSUE 77
630 SECRETION DISCHARGE 77
631 UPPER-AIRWAY COUGH SYNDROME 77
632 VAGINAL HAEMORRHAGE 77
633 APATHY 76
634 BLOOD POTASSIUM INCREASED 76
635 EYE MOVEMENT DISORDER 76
636 MUSCLE ATROPHY 76
637 PANCREATITIS ACUTE 76
638 DEAFNESS 75
639 DEVICE DIFFICULT TO USE 75
640 HALLUCINATIONS, MIXED 75
641 OBSESSIVE-COMPULSIVE DISORDER 75
642 PHARYNGITIS STREPTOCOCCAL 75
643 SKIN CANCER 75
644 STOMA SITE DISCHARGE 75
645 BACTERAEMIA 74
646 DENTAL CARIES 74
647 MOTOR DYSFUNCTION 74
648 OSTEOMYELITIS 74
649 PNEUMOTHORAX 74
650 THYROID DISORDER 74
651 ANKLE FRACTURE 73
652 OCULAR DISCOMFORT 73
653 PRODUCT ADHESION ISSUE 73
654 TENDONITIS 73
655 BLOOD UREA INCREASED 72
656 COORDINATION ABNORMAL 72
657 DRUG LEVEL INCREASED 72
658 LIVER FUNCTION TEST ABNORMAL 72
659 SCRATCH 72
660 SEDATION COMPLICATION 72
661 AGEUSIA 71
662 ATAXIA 71
663 INCORRECT PRODUCT ADMINISTRATION DURATION 71
664 PHOTOSENSITIVITY REACTION 71
665 QUALITY OF LIFE DECREASED 71
666 RHINOVIRUS INFECTION 71
667 SKIN HAEMORRHAGE 71
668 STATUS EPILEPTICUS 71
669 TACHYPNOEA 71
670 BURSITIS 70
671 GAMMA-GLUTAMYLTRANSFERASE INCREASED 70
672 GLAUCOMA 70
673 INTERNATIONAL NORMALISED RATIO INCREASED 70
674 KNEE ARTHROPLASTY 70
675 MOUTH ULCERATION 70
676 RESPIRATORY ARREST 70
677 ROTATOR CUFF SYNDROME 70
678 THERAPY CHANGE 70
679 VITAMIN D DEFICIENCY 70
680 ANGIOEDEMA 69
681 BRAIN INJURY 69
682 BREAST CANCER 69
683 DRUG EFFECT LESS THAN EXPECTED 69
684 INTERVERTEBRAL DISC DEGENERATION 69
685 NONSPECIFIC REACTION 69
686 POISONING DELIBERATE 69
687 PRODUCT PHYSICAL ISSUE 69
688 BIPOLAR DISORDER 68
689 MUSCLE SPASTICITY 68
690 ANTACID THERAPY 67
691 GLOSSODYNIA 67
692 IMPAIRED QUALITY OF LIFE 67
693 SENSORY DISTURBANCE 67
694 TEMPERATURE INTOLERANCE 67
695 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 67
696 APPLICATION SITE ERYTHEMA 66
697 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 66
698 ELECTROCARDIOGRAM ABNORMAL 66
699 GASTRIC ULCER 66
700 GLYCOSYLATED HAEMOGLOBIN INCREASED 66
701 MALIGNANT MELANOMA STAGE 0 66
702 SUBDURAL HAEMATOMA 66
703 SYSTEMIC LUPUS ERYTHEMATOSUS 66
704 TOOTH FRACTURE 66
705 AFFECT LABILITY 65
706 AFFECTIVE DISORDER 65
707 ANTICOAGULANT THERAPY 65
708 CHOLECYSTECTOMY 65
709 SCOLIOSIS 65
710 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 65
711 SPINAL OPERATION 65
712 CYST 64
713 HEREDITARY ANGIOEDEMA 64
714 INFUSION SITE DISCHARGE 64
715 INJECTION SITE RASH 64
716 SKIN INFECTION 64
717 SNORING 64
718 BLOOD CREATINE PHOSPHOKINASE INCREASED 63
719 ERECTILE DYSFUNCTION 63
720 FRUSTRATION TOLERANCE DECREASED 63
721 HEPATIC CIRRHOSIS 63
722 HEPATOTOXICITY 63
723 INJECTION SITE URTICARIA 63
724 JOINT DISLOCATION 63
725 NEUROLEPTIC MALIGNANT SYNDROME 63
726 TOOTH ABSCESS 63
727 WRONG TECHNIQUE IN DRUG USAGE PROCESS 63
728 ACUTE MYOCARDIAL INFARCTION 62
729 FOOD ALLERGY 62
730 INCREASED TENDENCY TO BRUISE 62
731 LUNG OPACITY 62
732 MUSCLE STRAIN 62
733 MYOCLONUS 62
734 NERVE INJURY 62
735 THERAPY PARTIAL RESPONDER 62
736 APPETITE DISORDER 61
737 CATATONIA 61
738 GLOMERULAR FILTRATION RATE DECREASED 61
739 HEPATIC FAILURE 61
740 JUVENILE IDIOPATHIC ARTHRITIS 61
741 POST-TRAUMATIC STRESS DISORDER 61
742 BOWEL MOVEMENT IRREGULARITY 60
743 CENTRAL NERVOUS SYSTEM LESION 60
744 DISABILITY 60
745 EYE INFECTION 60
746 HYPOCALCAEMIA 60
747 PAIN OF SKIN 60
748 PELVIC FRACTURE 60
749 POLYURIA 60
750 PULMONARY CONGESTION 60
751 SARS-COV-2 TEST POSITIVE 60
752 STEVENS-JOHNSON SYNDROME 60
753 UROSEPSIS 60
754 BONE DENSITY DECREASED 59
755 CONJUNCTIVITIS 59
756 DECREASED ACTIVITY 59
757 IMMUNE SYSTEM DISORDER 59
758 INTERSTITIAL LUNG DISEASE 59
759 LIGAMENT SPRAIN 59
760 PHARYNGEAL OEDEMA 59
761 PRODUCT PRESCRIBING ISSUE 59
762 PULMONARY FIBROSIS 59
763 SLUGGISHNESS 59
764 DRUG ADMINISTRATION ERROR 58
765 EUPHORIC MOOD 58
766 FLUID OVERLOAD 58
767 HAEMATEMESIS 58
768 HEMIPARESIS 58
769 PLEURITIC PAIN 58
770 STOMA SITE ERYTHEMA 58
771 TOTAL LUNG CAPACITY DECREASED 58
772 TUBULOINTERSTITIAL NEPHRITIS 58
773 URINE OUTPUT DECREASED 58
774 ABASIA 57
775 APHONIA 57
776 ECONOMIC PROBLEM 57
777 MITRAL VALVE INCOMPETENCE 57
778 NODULE 57
779 ORAL DISCOMFORT 57
780 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 57
781 SKIN ABRASION 57
782 ABNORMAL FAECES 56
783 BACK INJURY 56
784 DEVICE INFUSION ISSUE 56
785 INFUSION SITE EXTRAVASATION 56
786 NERVE COMPRESSION 56
787 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 56
788 SCAR 56
789 SHOCK 56
790 EJECTION FRACTION DECREASED 55
791 EPIDURAL LIPOMATOSIS 55
792 FEELING DRUNK 55
793 GINGIVAL BLEEDING 55
794 INFUSION SITE BRUISING 55
795 MASS 55
796 PARAESTHESIA ORAL 55
797 PROSTATE CANCER 55
798 TOOTH LOSS 55
799 AGRANULOCYTOSIS 54
800 ATELECTASIS 54
801 BLOOD MAGNESIUM DECREASED 54
802 GINGIVAL PAIN 54
803 METASTASES TO BONE 54
804 PARALYSIS 54
805 RESPIRATORY RATE INCREASED 54
806 SUICIDAL BEHAVIOUR 54
807 ABSCESS 53
808 DEVICE USE ISSUE 53
809 ESSENTIAL HYPERTENSION 53
810 EXPOSURE VIA SKIN CONTACT 53
811 FAILURE TO THRIVE 53
812 FOETAL EXPOSURE DURING PREGNANCY 53
813 GASTROINTESTINAL PAIN 53
814 GENERALISED OEDEMA 53
815 HAEMOGLOBIN INCREASED 53
816 HIP ARTHROPLASTY 53
817 OROPHARYNGEAL DISCOMFORT 53
818 PARADOXICAL DRUG REACTION 53
819 PNEUMONIA BACTERIAL 53
820 VITAMIN D DECREASED 53
821 WRIST FRACTURE 53
822 ACTIVITIES OF DAILY LIVING IMPAIRED 52
823 DISSOCIATION 52
824 EXOSTOSIS 52
825 HYPERNATRAEMIA 52
826 PULMONARY THROMBOSIS 52
827 RALES 52
828 SPLENOMEGALY 52
829 SUPRAVENTRICULAR TACHYCARDIA 52
830 APHTHOUS ULCER 51
831 APPLICATION SITE PRURITUS 51
832 BASAL CELL CARCINOMA 51
833 BLOOD GLUCOSE ABNORMAL 51
834 DECREASED INTEREST 51
835 FOOT DEFORMITY 51
836 HAIR COLOUR CHANGES 51
837 HUMERUS FRACTURE 51
838 IMPULSIVE BEHAVIOUR 51
839 MAJOR DEPRESSION 51
840 PERSONALITY CHANGE 51
841 PLATELET COUNT INCREASED 51
842 PRODUCT PREPARATION ISSUE 51
843 SENSORY LOSS 51
844 SEXUAL DYSFUNCTION 51
845 VENTRICULAR EXTRASYSTOLES 51
846 ADRENAL INSUFFICIENCY 50
847 DIABETIC KETOACIDOSIS 50
848 DRUG LEVEL DECREASED 50
849 FLANK PAIN 50
850 GASTROINTESTINAL INFECTION 50
851 GROIN PAIN 50
852 POSTURE ABNORMAL 50
853 VENTRICULAR TACHYCARDIA 50
854 BODY HEIGHT DECREASED 49
855 BRUXISM 49
856 DEVICE FAILURE 49
857 DRUG DOSE OMISSION BY DEVICE 49
858 EYE DISCHARGE 49
859 HYPERTHYROIDISM 49
860 ILEUS 49
861 JAUNDICE 49
862 LIBIDO DECREASED 49
863 REBOUND ACID HYPERSECRETION 49
864 RED CELL DISTRIBUTION WIDTH INCREASED 49
865 TUMOUR LYSIS SYNDROME 49
866 UPPER GASTROINTESTINAL HAEMORRHAGE 49
867 BLADDER DISORDER 48
868 BRAIN OEDEMA 48
869 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 48
870 COAGULOPATHY 48
871 HAND FRACTURE 48
872 HYPERCALCAEMIA 48
873 HYPOMAGNESAEMIA 48
874 IMPAIRED DRIVING ABILITY 48
875 PELVIC PAIN 48
876 VICTIM OF CHILD ABUSE 48
877 WOUND INFECTION 48
878 ARTHROPOD BITE 47
879 CYSTIC FIBROSIS 47
880 DERMATITIS 47
881 DRUG PRESCRIBING ERROR 47
882 ENERGY INCREASED 47
883 ENURESIS 47
884 GALLBLADDER DISORDER 47
885 LIVER INJURY 47
886 PETIT MAL EPILEPSY 47
887 REHABILITATION THERAPY 47
888 STOMA SITE INFECTION 47
889 VISUAL ACUITY REDUCED 47
890 BLOOD THYROID STIMULATING HORMONE INCREASED 46
891 BONE DISORDER 46
892 DEVICE USE ERROR 46
893 ELECTROLYTE IMBALANCE 46
894 ESCHERICHIA INFECTION 46
895 EYELID PTOSIS 46
896 FACIAL PARALYSIS 46
897 HYPERPARATHYROIDISM SECONDARY 46
898 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 46
899 INCORRECT DOSE ADMINISTERED BY DEVICE 46
900 INFUSION SITE INFECTION 46
901 INFUSION SITE MASS 46
902 LARYNGITIS 46
903 LUNG NEOPLASM MALIGNANT 46
904 PARTIAL SEIZURES 46
905 PRODUCT PREPARATION ERROR 46
906 SLOW SPEECH 46
907 TERMINAL STATE 46
908 TOOTH EXTRACTION 46
909 BLOOD ALBUMIN DECREASED 45
910 CARDIAC MURMUR 45
911 CHILD ABUSE 45
912 DIARRHOEA HAEMORRHAGIC 45
913 HAIR TEXTURE ABNORMAL 45
914 HYPOTHERMIA 45
915 INTENTIONAL UNDERDOSE 45
916 PROTEINURIA 45
917 RENAL CYST 45
918 RIGHT VENTRICULAR FAILURE 45
919 SJOGREN^S SYNDROME 45
920 WALKING AID USER 45
921 ARTERIOSCLEROSIS 44
922 AUTISM SPECTRUM DISORDER 44
923 BLOOD CALCIUM DECREASED 44
924 BLOOD PRESSURE DIASTOLIC DECREASED 44
925 CARDIOMYOPATHY 44
926 DRY THROAT 44
927 EXERCISE TOLERANCE DECREASED 44
928 MALIGNANT MELANOMA 44
929 SPINAL PAIN 44
930 VASCULAR DEVICE INFECTION 44
931 VITREOUS FLOATERS 44
932 EAR DISCOMFORT 43
933 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 43
934 HEPATOMEGALY 43
935 INCOHERENT 43
936 OCULOGYRIC CRISIS 43
937 OESOPHAGITIS 43
938 PRODUCT DISPENSING ERROR 43
939 PRURITUS GENERALISED 43
940 SCAB 43
941 SPINAL DISORDER 43
942 ATRIAL FLUTTER 42
943 AUTOIMMUNE DISORDER 42
944 CHRONIC SINUSITIS 42
945 DEVICE KINK 42
946 DYSMENORRHOEA 42
947 GASTROENTERITIS 42
948 HEPATITIS 42
949 HYPERVENTILATION 42
950 MELAENA 42
951 MENSTRUATION DELAYED 42
952 PANIC REACTION 42
953 PRODUCT TASTE ABNORMAL 42
954 RESPIRATORY SYMPTOM 42
955 SELF-INJURIOUS IDEATION 42
956 SENSITIVE SKIN 42
957 ABORTION SPONTANEOUS 41
958 APPLICATION SITE PAIN 41
959 CATHETER SITE PAIN 41
960 CEREBRAL DISORDER 41
961 DEMENTIA ALZHEIMER^S TYPE 41
962 DEVICE PHYSICAL PROPERTY ISSUE 41
963 ESCHERICHIA URINARY TRACT INFECTION 41
964 FACIAL PAIN 41
965 GASTROINTESTINAL MOTILITY DISORDER 41
966 HAEMORRHAGE INTRACRANIAL 41
967 HYPERTHERMIA 41
968 HYPOTONIA 41
969 HYPOVOLAEMIA 41
970 INTERNAL HAEMORRHAGE 41
971 KNEE OPERATION 41
972 LUNG INFECTION 41
973 METASTASES TO LYMPH NODES 41
974 PAROSMIA 41
975 PROSTATIC SPECIFIC ANTIGEN INCREASED 41
976 PURPURA 41
977 SOPOR 41
978 ACUTE RESPIRATORY DISTRESS SYNDROME 40
979 ATTENTION DEFICIT HYPERACTIVITY DISORDER 40
980 BODY TEMPERATURE DECREASED 40
981 CARBOHYDRATE ANTIGEN 125 INCREASED 40
982 CEREBRAL INFARCTION 40
983 DIABETIC NEUROPATHY 40
984 ELECTRIC SHOCK SENSATION 40
985 FORMICATION 40
986 GLUCOSE TOLERANCE IMPAIRED 40
987 HANGOVER 40
988 HEPATOCELLULAR INJURY 40
989 HYPERKERATOSIS 40
990 HYPERPHAGIA 40
991 INCORRECT DRUG ADMINISTRATION DURATION 40
992 INJECTION SITE WARMTH 40
993 LACERATION 40
994 MACULAR DEGENERATION 40
995 NEOPLASM 40
996 OBSTRUCTION 40
997 SPINAL STENOSIS 40
998 STOMA SITE PAIN 40
999 TENDON RUPTURE 40